Search by Drug Name or NDC
NDC 16571-0810-01 Trientine Hydrochloride 250 mg/1 Details
Trientine Hydrochloride 250 mg/1
Trientine Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is TRIENTINE HYDROCHLORIDE.
Product Information
| NDC | 16571-0810 |
|---|---|
| Product ID | 16571-810_642b3258-7418-4209-bb88-2ca277a4fb2b |
| Associated GPIs | 99200020100110 |
| GCN Sequence Number | 002554 |
| GCN Sequence Number Description | trientine HCl CAPSULE 250 MG ORAL |
| HIC3 | C8A |
| HIC3 Description | METALLIC POISON,AGENTS TO TREAT |
| GCN | 00720 |
| HICL Sequence Number | 001109 |
| HICL Sequence Number Description | TRIENTINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Trientine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Trientine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRIENTINE HYDROCHLORIDE |
| Labeler Name | Rising Pharma Holdings, Inc. |
| Pharmaceutical Class | Copper Chelating Activity [MoA], Copper Chelator [EPC], Metal Chelating Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212238 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16571-0810-01 (16571081001)
| NDC Package Code | 16571-810-01 |
|---|---|
| Billing NDC | 16571081001 |
| Package | 100 CAPSULE in 1 BOTTLE (16571-810-01) |
| Marketing Start Date | 2021-03-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |